Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.

Abstract

References

Systemic Castleman's disease in association with Evan's syndrome and vitiligo.

Evans syndrome: results of a national survey

The spectrum of Evans' syndrome

Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders

Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome

Severe Evans's syndrome secondary to interleukin-2 therapy: treatment with chimeric monoclonal anti-CD20 antibody

Allogeneic stem cell transplantation for Evans syndrome

Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura.

Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children.

Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder

Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome

Rituximab treatment for relapsed autoimmune hemolytic anemia in Evans syndrome

Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases

Fludarabine-induced hemolytic anemia: successful treatment by rituximab

Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology

Monoclonal antibodies in the treatment of autoimmune cytopenias

Fatal Evans' syndrome after matched unrelated donor transplantation for hyper-IgM syndrome

Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases

CD5-negative chronic lymphocytic leukemia with indolent clinical course and autoimmune thrombocytopenia, successfully treated with rituximab

Management of Evans syndrome

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia

Monoclonal antibody therapy for B-cell malignancies

Methods Mentioned

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

Autoimmune Hemolytic Anemia

Related Papers

Intractable autoimmune hemolytic anemia in B cell chronic lymphocytic leukemia resolved by Rituximab

Efficacy of therapy with anti-CD20 antibody (rituximab) in a patient with autoimmune hemolytic anemia associated

Rituximab for child with chronic relapsing autoimmune hemolytic anemia

Rituximab in patients with refractory autoimmune hemolytic anemia

Cold autoimmune hemolytic anemia resolved by rituximab